FDA Inspection 1163608 — Max Health, Subsero Health
The FDA completed an inspection of Max Health, Subsero Health on Mar 4, 2022 in Sarasota, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 4, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Sarasota, FL (United States)
Additional Details
Sponsor, Contract Research Organization
Citations
| ID | CFR | Description |
|---|---|---|
| 7638 | 21 CFR 312.20(a) | Failure to submit an IND |